Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers

Neurology

Volumn 75, Issue 17, 2010, Pages 1520-1526

  Asghar, M S ^a   Hansen, A E ^b   Kapijimpanga, T ^a   Van Der Geest, R J ^c   Van Der Koning, P ^c   Larsson, H B W ^a   Olesen, J ^a   Ashina, M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Functional Imaging Unit   (Denmark)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CALCITONIN GENE RELATED PEPTIDE; PLACEBO; SUMATRIPTAN;

ADULT; ANTINOCICEPTION; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE MONITORING; BRAIN ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HEADACHE; HEART RATE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE MENINGEAL ARTERY; NORMAL HUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

ADULT; AREA UNDER CURVE; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HEADACHE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL ARTERIES; MIDDLE CEREBRAL ARTERY; SUMATRIPTAN; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS; YOUNG ADULT;

EID: 78149272453     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f9626a     Document Type: Article

References (31)

1. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-187.
2. Brain S, Cambridge H. Calcitonin gene-related peptide: vasoactive effects and potential therapeutic role. Gen Pharmacol 1996;27:607-611.
3. Lassen L, Haderslev P, Jacobsen V, Iversen H, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002;22:54-61.
4. Arulmani U, Massenvandenbirk A, Villalon C, Saxena P. Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol 2004;500:315-330.
5. McCulloch J, Uddman R, Kingman TA, Edvinsson L. Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci USA 1986;83:5731-5735.
6. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985;313:54-56.
7. Oliver KR, Wainwright A, Edvinsson L, Pickard JD, Hill RG. Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 2002;22:620-629.
8. Petersen KA, Lassen LH, Birk S, Lesko L, Olesen J. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 2005;77:202-213.
9. Lassen LH, Jacobsen VB, Haderslev PA, et al. Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients. J Headache Pain 2008;9:151-157.
10. Petersen K, Birk S, Lassen L, et al. The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 2005;25:139-147.
11. Hansen J, Pedersen D, Larsen V, et al. Magnetic resonance angiography shows dilatation of the middle cerebral artery after infusion of glyceryl trinitrate in healthy volunteers. Cephalalgia 2007;27:118-127.
12. Schoonman G, Van der Grond J, Kortmann C, et al. Migraine headache is not associated with cerebral or meningeal vasodilatation: a 3T magnetic resonance angiography study. Brain 2008;131:2192-2200.
13. Iversen H, Olesen J, Tfelt-Hansen P. Intravenous nitroglycerin as an experimental model of vascular headache: basic characteristics. Pain 1989;38:17-24.
14. de Koning P, Schaap, Janssen J, Westenberg J, Van der Geest R, Reiber J. Automated segmentation and analysis of vascular structures in magnetic resonance angiographic images. Magn Reson Med 2003;50:1189-1198.
15. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-235.
16. Petersen K, Birk S, Doods H, Edvinsson L, Olesen J. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat. Br J Pharmacol 2004;143:697-704.
17. Jansen-Olesen I, Engel U, Edvinsson L. In-depth characterization of CGRP receptors in human intracranial arteries. Eur J Pharmacol 2003;481:207-216.
18. Gupta S, Mehrotra S, Avezaat CJJ, Villalón CM, Saxena PR, Maassenvandenbrink A. Characterisation of CGRP receptors in the human isolated middle meningeal artery. Life Sci 2006;79:265-271.
19. Petersen K, Nilsson E, Olesen J, Edvinsson L. Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo. Cephalalgia 2005;25:424-432.
20. Humphrey PP, Goadsby PJ. The mode of action of sumatriptan is vascular? A debate. Cephalalgia 1994;14:401-410.
21. Ahn A, Basbaum A. Where do triptans act in the treatment of migraine? Pain 2005;115:1-4.
22. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56.
23. Juhasz G, Zsombok T, Jakab B, et al. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) contraction and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 2005;25:179-183.
24. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 2000;20:907-918.
25. Durham PL, Russo AF. Regulation of calcitonin generelated peptide secretion by a serotonergic antimigraine drug. J. Neurosci 1999;19:3423-3429.
26. Ferrari, M, Saxena P. Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci 1993;14:129-133.
27. Cumberbatch M, Williamson D, Mason G, Hill R, Hargreaves R. Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist. Br J Pharmacol 1999;126:1478-1486.
28. Eltorp CT, Jansen-Olesen I, Hansen AJ. Release of calcitonin gene-related peptide (CGRP) from guinea pig dura mater in vitro is inhibited by sumatriptan but unaffected by nitric oxide. Cephalalgia 2000;20:838-844.
29. Hansen JM, Petersen J, Wienecke T, Olsen K, Jensen L, Ashina M. Sumatriptan does not change calcitonin generelated peptide in the cephalic and extracephalic circulation in healthy volunteers. J Headache Pain 2009;10:85-91.
30. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002;22:633-658.
31. Lacey LF, Hussey EK, Fowler PA. Single dose pharmacokinetics of sumatriptan in healthy volunteers. Eur J Clin Pharmacol 1995;47:543-548.